Related Experiment Video
Updated: Apr 11, 2026
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Aβ25-35 Suppresses Mitochondrial Biogenesis in Primary Hippocampal Neurons
Weiguo Dong1, Feng Wang2, Wanqing Guo3
1Department of Integrated Traditional Chinese and Western Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, Fujian, People's Republic of China. fjdwg601@163.com.
Abstract:
Mitochondrial biogenesis is involved in the regulation of mitochondrial content, morphology, and function. Impaired mitochondrial biogenesis has been observed in Alzheimer's disease. Amyloid-β (Aβ) has been shown to cause mitochondrial dysfunction in cultured neurons, but its role in mitochondrial biogenesis in neurons remains poorly defined. AMP-activated protein kinase (AMPK) and sirtuin 1 (SIRT1) are key energy-sensing molecules regulating mitochondrial biogenesis. In addition, peroxisome proliferator-activated receptor-γ coactivator 1-alpha (PGC-1α), the master regulator of mitochondrial biogenesis, is a target for SIRT1 deacetylase activity. In this study, we investigated the effects of Aβ25-35 on mitochondrial biogenesis in cultured hippocampal neurons and the underlying mechanisms. In primary hippocampal neurons, we found that 24-h incubation with Aβ25-35 suppressed both phosphorylations of AMPK and SIRT1 expression and increased PGC-1α acetylation expression. In addition, Aβ25-35 also resulted in a decrease in mitochondrial DNA copy number, as well as decreases in the expression of mitochondrial biogenesis factors (PGC-1α, NRF 1, NRF 2, and Tfam). Taken together, these data show that Aβ25-35 suppresses mitochondrial biogenesis in hippocampal neurons. Aβ25-35-induced impairment of mitochondrial biogenesis may be associated with the inhibition of the AMPK-SIRT1-PGC-1α pathway.
Insights
Amyloid-beta (Aβ) peptide fragments impair mitochondrial biogenesis in hippocampal neurons by inhibiting the AMPK-SIRT1-PGC-1α pathway. This disruption affects mitochondrial function and may contribute to Alzheimer's disease pathogenesis.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Mitochondrial biogenesis is crucial for neuronal health, regulating mitochondrial content, morphology, and function.
- Impaired mitochondrial biogenesis is implicated in Alzheimer's disease (AD).
- Amyloid-beta (Aβ) peptides are known to cause mitochondrial dysfunction, but their precise role in neuronal mitochondrial biogenesis is unclear.
Purpose of the Study:
- To investigate the effects of the Aβ25-35 peptide fragment on mitochondrial biogenesis in cultured hippocampal neurons.
- To elucidate the underlying molecular mechanisms, focusing on the AMPK-SIRT1-PGC-1α pathway.
Main Methods:
- Primary hippocampal neurons were treated with Aβ25-35 for 24 hours.
- Assessed phosphorylation of AMP-activated protein kinase (AMPK).
- Measured expression of SIRT1, PGC-1α, NRF 1, NRF 2, and Tfam, as well as PGC-1α acetylation and mitochondrial DNA copy number.
Main Results:
- Aβ25-35 treatment suppressed AMPK phosphorylation and reduced SIRT1 expression.
- Aβ25-35 increased PGC-1α acetylation and decreased the expression of key mitochondrial biogenesis factors (PGC-1α, NRF 1, NRF 2, Tfam).
- Aβ25-35 treatment led to a significant decrease in mitochondrial DNA copy number.
Conclusions:
- Aβ25-35 peptide fragment suppresses mitochondrial biogenesis in hippocampal neurons.
- The observed impairment is associated with the inhibition of the energy-sensing AMPK-SIRT1-PGC-1α pathway.
- These findings suggest a potential mechanism linking Aβ pathology to mitochondrial dysfunction in Alzheimer's disease.
